Reliance Big TV offer: 500 channels free for 5 yrs, HD ones for 1 year

1. Fortis reports consolidated net loss of Rs 191 million for Dec quarter Fortis Healthcare on Thursday reported a consolidated net loss of Rs 191 million for the quarter ended December 2017 against a profit of Rs 4.5 billion year-ago periods. The company also reported its September quarter net loss at Rs 236.1 million after it had sought a 15-day extension to declare earnings for the second and third quarter of the current financial year citing statutory auditors' inability to complete the audit before the stipulated board meeting. Although the company presented its earnings report, the auditor to Fortis Healthcare, Deloitte Haskins & Sells LLP, said it had not performed an audit. It said the interim results have been reviewed by other auditors whose report has been furnished to them by the management. "Because of the significance of the matters... relating to the ongoing investigations... we were not able to obtain sufficient appropriate evidence to form a conclusion on the statement," it added.

2. The results of Fortis Healthcare come amid controversy and scrutiny of the company's finances over alleged regulatory lapses in transfer of funds to some promoter-linked firms. In an early morning regulatory filing, the company presented its earnings for the second and third quarter of the ongoing fiscal. Total income during the December quarter stood at Rs 11.6 billion. It was Rs 11.9 billion in the same quarter previous fiscal. For the quarter ended September 2017, income was reported at Rs 12.3 billion. Meanwhile, shares of the company were trading flat at Rs 159.75 apiece on BSE. Fortis Healthcare landed into trouble after a media report claiming that the company's promoters, Malvinder Mohan Singh and Shivinder Mohan Singh, took at least USD 78 million (about Rs 5 billion at current exchange rate) out of the publicly-traded hospital company they control without board approval about a year ago. The company said its wholly-owned arm Fortis Hospitals had deployed funds to the tune of Rs 4 billion as secured short-term investments to group firms of its promoters. The move attracted regulatory scrutiny as Sebi began examining the issues following resignation of the two promoters from the board. The company said the loans are adequately secured and repayment has since commenced as per agreed payment schedule. The company's statutory auditor said Sebi is conducting an investigation in respect of secured short-term investment of Rs 4.7 billion made by the wholly- owned subsidiary of the parent, and pending completion of the investigation, it is unable to "conclude on effects, if any of the outcome of the same on the financial results, state of affairs, cash flows, and operations of the group". Article By - Business Standard